Osteoporosis International

Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis. 2021

Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture (Osteoporosis International, (2020), 10.1007/s00198-020-05734-0) 2021

Racial disparities, FRAX, and the care of patients with osteoporosis.  31:2069-2071. 2020

Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.  31:1283-1290. 2020

Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017.  31:1299-1304. 2020

Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures (Osteoporosis International, (2020), 31, 1, (1-12), 10.1007/s00198-019-05176-3).  31:797-798. 2020

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.  31. 2020

Real-world bone turnover marker use: impact on treatment decisions and fracture 2020

Glucocorticoid-induced osteoporosis: 2019 concise clinical review.  30:1145-1156. 2019

Sex differences in osteoporosis self-efficacy among community-residing older adults presenting for DXA.  30:1033-1041. 2019

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation.  30:45-57. 2019

Risk of subsequent fracture after prior fracture among older women.  30:79-92. 2019

Correction to: Hip fracture trends in the United States, 2002 to 2015 (Osteoporosis International, (2018), 29, 3, (717-722), 10.1007/s00198-017-4345-0).  29:2583. 2018

Dietary patterns and longitudinal change in hip bone mineral density among older men.  29:1135-1145. 2018

The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.  29:859-870. 2018

Hip fracture trends in the United States, 2002 to 2015.  29:717-722. 2018

High dairy protein intake is associated with greater bone strength parameters at the distal radius and tibia in older men: a cross-sectional study.  29:69-77. 2018

Self-perception of fracture risk: what can it tell us?.  28:3495-3500. 2017

Validity, reliability, and responsiveness to change of the “Osteoporosis and You” knowledge scale.  28:3379-3388. 2017

The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation.  28:3283-3284. 2017

The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial.  28:3061-3066. 2017

The effects of a patient activation intervention on smoking and excessive drinking cessations: results from the PAADRN randomized controlled trial.  28:3055-3060. 2017

Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (Osteoporosis International, (2017), 28, 8, (2495-2503), 10.1007/s00198-017-4073-5).  28:2505. 2017

Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.  1-9. 2017

The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.  28:1225-1232. 2017

Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial.  27:3513-3524. 2016

Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.  27:3239-3249. 2016

The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials.  27:2655-2671. 2016

Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men.  27:2291-2300. 2016

The effects of state-level expenditures for home- and community-based services on the risk of becoming a long-stay nursing home resident after hip fracture.  27:953-961. 2016

Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance).  26:1971-1977. 2015

An evaluation of clinical risk factors for estimating fracture risk in postmenopausal osteoporosis using an electronic medical record database.  26:581-587. 2015

Underdevelopment of trabecular bone microarchitecture in the distal femur of nonambulatory children with cerebral palsy becomes more pronounced with distance from the growth plate..  26:505-512. 2015

International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.  26:419-420. 2015

The effect of a 3-month moderate-intensity physical activity program on body composition in overweight and obese African American college females.  25:2485-2491. 2014

The clinical diagnosis of osteoporosis: A position statement from the National Bone Health Alliance Working Group.  25:1439-1443. 2014

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.  25:85-95. 2014

Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass.  25:317-324. 2014

Multimodal intervention to improve osteoporosis care in home health settings: Results from a cluster randomized trial.  24:2555-2560. 2013

Association between osteoporosis treatment change and adherence, incident fracture, and total healthcare costs in a Medicare Advantage Prescription Drug plan.  24:1195-1206. 2013

Performance of FRAX in a cohort of community-dwelling, ambulatory older men: The Osteoporotic Fractures in Men (MrOS) study.  24:1185-1193. 2013

Magnitude and consequences of misclassification of incident hip fractures in large cohort studies: The Study of Osteoporotic Fractures and Medicare claims data.  24:801-810. 2013

Non-hip, non-spine fractures drive healthcare utilization following a fracture: The Global Longitudinal Study of Osteoporosis in Women (GLOW).  24:59-67. 2013

Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: The Global Longitudinal study of Osteoporosis in Women (GLOW).  23:2863-2871. 2012

Acknowledgments for "best practices in systems-based interventions to reduce the burden of fractures" (Osteoporosis International Volume 22, Supplement 3, August 2011).  23:2393-2394. 2012

Defining physiologically "normal" vitamin D in African Americans.  23:2283-2291. 2012

Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: The Global Longitudinal Study of Osteoporosis in Women.  23:2179-2188. 2012

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.  23:2141-2150. 2012

Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.  23:1083-1090. 2012

Improving osteoporosis care through multimodal interventions: Insights from the University of Alabama at Birmingham Center for Education and Research on Therapeutics.  22. 2011

Systems-based approaches to osteoporosis and fracture care: Policy and research recommendations from the workgroups.  22. 2011

Medical costs of osteoporosis in the elderly Medicare population.  22:1835-1844. 2011

Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey.  22:1745-1753. 2011

Ethnic differences in femur geometry in the women's health initiative observational study.  22:1377-1388. 2011

Erratum: Clinical and demographic factors associated with fractures among older Americans (Osteoporosis International DOI: 10.1007/s00198-010-1300-8).  22:1275-1276. 2011

Genetic analysis of vertebral trabecular bone density and cross-sectional area in older men.  22:1079-1090. 2011

An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis.  22:305-315. 2011

Clinical and demographic factors associated with fractures among older Americans.  22:1263-1274. 2011

Failure to perceive increased risk of fracture in women 55 years and older: The Global Longitudinal Study of Osteoporosis in Women (GLOW).  22:27-35. 2011

Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis.  21:1573-1584. 2010

Hip structural geometry and incidence of hip fracture in postmenopausal women: What does it add to conventional bone mineral density?.  21:919-929. 2010

"pathologic" fractures: Should these be included in epidemiologic studies of osteoporotic fractures?.  20:1969-1972. 2009

Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research.  20:1921-1927. 2009

Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data.  20:1507-1515. 2009

The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States.  20:1553-1561. 2009

The Global Longitudinal Study of Osteoporosis in Women (GLOW): Rationale and study design.  20:1107-1116. 2009

RisedronatE and ALendronate intervention over three years (REALITY): Minimal differences in fracture risk reduction.  20:973-978. 2009

Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: A population-based cohort study.  20:819-826. 2009

Risk of hip fracture after bisphosphonate discontinuation: Implications for a drug holiday.  19:1613-1620. 2008

Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture.  18:553-559. 2007

Endogenous sex steroids, weight change and rates of hip bone loss in older men: The MrOS study.  17:1329-1336. 2006

Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users.  17:1268-1274. 2006

Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density.  17:61-67. 2006

Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment.  16:1545-1557. 2005

Oral contraceptives and bone mineral density in white and black women in CARDIA.  13:893-900. 2002

Mapping of quantitative ultrasound of the calcaneus bone to chromosome 1 by genome-wide linkage analysis.  13:796-802. 2002